Guosen Securities responded to the “search report portal”: is actively contacting iKang Guobin to communicate directly on the relevant situation

Original title: Guosen Securities responded to the “research report gate”: actively contact iKang Guobin to communicate directly on the relevant situation

Summary

[Guoxin Securities ha risposto alla “porta di ricerca”: contattando attivamente iKang Guobin per comunicare direttamente sulla situazione rilevante]Regarding the relationship with the real name of two securities analysts of Guosen Securities, Guosen Securities replied to reporters: “Guosen Securities has been Since it carried out the business of issuing research reports on securities in accordance with laws and regulations , the company’s securities analyst mentioned iKang Guobin in an audit report of a listed company, but the logic of the report itself is not to discuss the possibility of cooperation between related companies. It may be that all parties The interpretation of the individual expressions in the text is inconsistent, which has caused some misunderstandings. We are actively contacting iKang Guobin to communicate directly with the relevant situation and try to eliminate related misunderstandings. We will also respond to iKang Guobin’s complaints with securities regulators. actively with the work of the relevant departments. “(21st Century Business Herald)

Early in the morning of November 13, for iKang Guobin on WeChatpublicChina Securities Regulatory and AdministrationCommittee, Shenzhen Supervision Bureau of China Securities Regulatory Commission,China Securities Industry AssociationRelationship with the real nameGuosen SecuritiesTwo titles subordinateAnalystOne thing,Guosen SecuritiesTo the 21st Century Business Herald reporter: “Guosen SecuritiesIt has issued securities in accordance with laws and regulationsresearch reportbusiness,the companySecurities analyst in an audit of a public companyrelationshipIkang Guobin was mentioned in the article, but the logic of the relationship itself is not to discuss the possibility of cooperation between related companies. It is possible that various parts have inconsistent interpretations of the individual expressions of the text, which has caused some misunderstandings. We are actively contacting iKang state hosts to communicate directly about the relevant situation and strive to eliminate relevant misunderstandings. In response to iKang Guobin’s complaints to securities regulators, we will also actively cooperate with relevant authorities. “works。“

This report letter is related to a research report recently published by Guosen Securities.

Since last week, the Great White Horse StockMeinian Health(002044) It plummeted for 5 consecutive days, the stock price fell more than 29% in one week,Market valueIt shrank by nearly 20 billion yuan – a lotmarketPeople speculate that this collapse and the reduction of Ali in holdings and listed companiesPerformanceNot up to the expectations related.

Released by the Guosen Securities Research Institute Pharmaceutical Industry Group on November 6Research report—— 《Meinian Health: The accident happened for a reason, explore Alistrategy“The report commented on the corporate status and development of iKang Guobin in the main text.

The analyst said in the research report: “RecentlyMeinian HealthWe value and the keyshareholderThe reduction in holdings is closely related, and according to our analysis, we suspect that the underlying cause could be that Ali avoided becoming a controlling shareholder and was forced to find a solution.Industry competitionIKang Guest Injection Process and Questions. “

The analyst also pointed out: “Considering the approach of the new corona vaccine listing, the impact of the new corona epidemic will have a positive impact. Both the pressure on capital demand from controlling shareholders and those acting as concert, both Meinian Health’s business conditions follow-up prospects gradually improved. Therefore, we believe that only based on a small amount of reduction, we currently believe that AliinvestmentThe “healthy China” strategy has changed and is too hasty. “

The analysis report on the collapse of health caused by the reduction in Ali’s holdings “angered” the state host from Ikang.

On November 10, iKang Guobin released a special statement stating that Guosen Securities analysts had never asked for confirmation or consultation with iKang Guobin during the process of writing the report and that there was no merger or merger between iKang Guobin and Meinian Health. .ReorganizationIntent, such misleading statements will adversely affect iKang Guobin’s normal operations.

At the same time, iKang Guobin also said he had releasedlawyerThe lawyer’s letter not only requires Guosen Securities to eliminate the negative effects on iKang Guobin, but also requires Guosen Securities to investigate whether the report is compliant.

It is worth noting that Ikang Guobin also mentioned a key figure: Meinian Healthvice president, Secretary of the Board of Directors Jiang Weina.According to information from the Securities Association, Jiang Weina worked at Guosen Securities from 2015 to 2018 and moved toGuoyuan SecuritiesOn June 15 this year, Meinian Health passed a board resolution to hire Jiang Weina as the company’s deputy.President, Secretary of the Board of Directors.

In the lawyer’s letter, iKang Guobin argued that Guosen Securities had been asked to confirm whether Jiang Weina’s working history with Guosen Securities would affect the independence and objectivity of Guosen Securities’ health research and analysis report. Meinian and whether Jiang Weina directly or indirectly participated in the aforementioned Guosen Medical Reporting or whether Jiang Weina has indicated or implied that such securities analysts have written the above reports and whether Jiang Weina has provided material information in violation of the Law on securities and related regulations.

Guosen Securities denied this, stating that since Jiang Weina left Guosen Securities for personal reasons in May 2018, he has not directly or indirectly participated in the writing and publication of any Guosen Securities research report. During Jiang Weina’s work with others institutions, there has never been aadAny private exchange of content.

(Source: 21st Century Business Herald)

(Responsible publisher: DF353)